Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. (Q45271809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15718384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15718384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15718384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Alvin C Haver

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15718384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Roger D Reidelberger

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15718384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

17 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15718384%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15718384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15718384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15718384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

R1695-706

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15718384%20AND%20SRC:MED&resulttype=core&format=json

Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Interaction with grp58 increases activity of the thiazide-sensitive Na-Cl cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Minireview: the glucagon-like peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Decreased intake of a liquid diet in nonfood-deprived rats following intra-PVN injections of GLP-1 (7-36) amide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Gastrointestinal satiety signals II. Cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Gastric satiation is volumetric, intestinal satiation is nutritive

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Gastrointestinal mechanisms of satiation for food

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Effects of glucagon-like peptide-1(7-36)amide on motility and sensation of the proximal stomach in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Autoradiographic localization of receptors for glucagon-like peptide-1 (7-36) amide in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Incretins, insulin secretion and Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression1This work was supported by a grant from the Crohn's and Colitis Foundation of America.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004

Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00870.2004